USNA logo

USANA HEALTH SCIENCES INC

USNANYSE
πŸ† #3488 by market capEarnings Oct 27 Β· PostUS Equity
$252.91β–² $2.53 (+1.00%)
Simulated price
πŸ””
Track USNA
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.0%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$268M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+8.3%
Slowing
πŸ“ŠGross Margin
77.5%
High
πŸ’΅FCF Margin
1.7%
Thin
βš–οΈP/S Ratio
0.3x
Cheap
Otter Score
60
Fair
No chart data available for USNA.

Trading Snapshot

Day Range
$249.41 – $257.65
52-Week Range
$12.57 – $28.52
Volume
$2.83B
Avg Volume
$3.59B
Shares Outstanding
18.5M
Next Earnings
Nov 30, 2026

Fundamentals Snapshot

Annual Revenue
$925M
Last Q Revenue
$223M
P/E Ratio
-12.0
P/S Ratio
0.3x
EPS (TTM)
$-1.20
Dividend Yield
0.00%
Dilution (1yr)
+1.1%

Why Investors Own USNA

  • βœ“High-growth profile β€” revenue up +33.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 33% gross margin and 17% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

USNA logo

USANA HEALTH SCIENCES INC

USNA
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$925Mβ–² +8.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
78.3%β–Ό βˆ’1.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$51Mβ–Ό βˆ’23.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$9Mβ–Ό βˆ’83.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
18.5Mβ–² +1.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$169Mβ–² +$23M YoY
StockOtter Β· stockotter.space

About USANA HEALTH SCIENCES INC

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Ratings

β“˜
Consensus
Sell
6 analysts
Strong Buy0
Buy0
Hold3
Sell1
Strong Sell2
Ratings as of Jun 2025

Latest News & Updates